Neomycin And Polymyxin B Sulfates, Bacitracin Zinc
NDC Package 57237-129-53

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Neomycin And Polymyxin B Sulfates, Bacitracin Zinc is a . Marketed by Rising Pharma Holdings, Inc., this product is identified by NDC 57237-129 and is authorized under FDA application NDA050417.

Identification & Billing

NDC Package Code
57237-129-53
Package Description
1 TUBE in 1 CARTON / 3.5 g in 1 TUBE
Product Code
57237-129
11-Digit Billing Format
57237012953
Billing Unit
GM - Billing unit of "gram" is used when a product is measured by its weight.
Units Per Package
3.5 GM

Clinical Specifications

Proprietary Name
Neomycin And Polymyxin B Sulfates, Bacitracin Zinc
Dosage Form
-

Regulatory & Marketing

Labeler Name
Rising Pharma Holdings, Inc.
FDA Application #
NDA050417
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
04-10-2017
End Marketing Date
08-14-2023
Listing Expiration
08-14-2023
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 57237-129-53 identifies a specific commercial package of 1 tube in 1 carton / 3.5 g in 1 tube of Neomycin And Polymyxin B Sulfates, Bacitracin Zinc, labeled by Rising Pharma Holdings, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Rising Pharma Holdings, Inc. on April 10, 2017. The current certification is valid through August 14, 2023.

How is this Rising Pharma Holdings, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 57237012953. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 3.5 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
57237-129-53
11-Digit CMS (5-4-2)
57237-0129-53

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.